Vyne Therapeutics Stock Forecast

Sell candidate since Jun 12, 2026

The Vyne Therapeutics Inc stock price fell by -2.47% on the last day (Friday, 12th Jun 2026) from $0.665 to $0.649. During the last trading day the stock fluctuated 3.08% from a day low at $0.645 to a day high of $0.665. The price has been going up and down for this period, and there has been a -4.9% loss for the last 2 weeks. Volume has increased on the last day by 49 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 83 thousand shares were bought and sold for approximately $53.59 thousand.

Given the current short-term trend, the stock is expected to rise 14.29% during the next 3 months and, with a 90% probability hold a price between $0.741 and $0.80 at the end of this 3-month period.

VYNE Signals & Forecast

There are few to no technical positive signals at the moment. The Vyne Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.660 and $0.664. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -5.59%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Vyne Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Vyne Therapeutics Inc stock

Vyne Therapeutics Inc finds support from accumulated volume at $0.633 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0199 between high and low, or 3.08%. For the last week the stock has had daily average volatility of 3.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VYNE) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Vyne Therapeutics Inc to open at $0.653, and during the day (based on 14 day Average True Range), to move between $0.637 and $0.660, which gives a possible trading interval of +/-$0.0225 (+/-3.53%) up or down from last closing price. If Vyne Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 3.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.656 (1.16%) than the support at $0.633 (2.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Vyne Therapeutics Inc stock A Buy?

The Vyne Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Vyne Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.535 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $0.653 ( 0.673%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk